Literature DB >> 28716398

Serotonin depletion increases seizure susceptibility and worsens neuropathological outcomes in kainate model of epilepsy.

Gisela H Maia1, Cátia S Brazete2, Joana I Soares3, Liliana L Luz4, Nikolai V Lukoyanov5.   

Abstract

Serotonin is implicated in the regulation of seizures, but whether or not it can potentiate the effects of epileptogenic factors is not fully established. Using the kainic acid model of epilepsy in rats, we tested the effects of serotonin depletion on (1) susceptibility to acute seizures, (2) development of spontaneous recurrent seizures and (3) behavioral and neuroanatomical sequelae of kainic acid treatment. Serotonin was depleted by pretreating rats with p-chlorophenylalanine. In different groups, kainic acid was injected at 3 different doses: 6.5mg/kg, 9.0mg/kg or 12.5mg/kg. A single dose of 6.5mg/kg of kainic acid reliably induced status epilepticus in p-chlorophenylalanine-pretreated rats, but not in saline-pretreated rats. The neuroexcitatory effects of kainic acid in the p-chlorophenylalanine-pretreated rats, but not in saline-pretreated rats, were associated with the presence of tonic-clonic convulsions and high lethality. Compared to controls, a greater portion of serotonin-depleted rats showed spontaneous recurrent seizures after kainic acid injections. Loss of hippocampal neurons and spatial memory deficits associated with kainic acid treatment were exacerbated by prior depletion of serotonin. The present findings are of particular importance because they suggest that low serotonin activity may represent one of the major risk factors for epilepsy and, thus, offer potentially relevant targets for prevention of epileptogenesis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-Hydroxytryptamine; Dorsal raphe; Hippocampal formation; Kainate; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2017        PMID: 28716398     DOI: 10.1016/j.brainresbull.2017.07.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  5 in total

1.  Serotonin abnormalities in Dravet syndrome mice before and after the age of seizure onset.

Authors:  Paul G Hatini; Kathryn G Commons
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

Review 2.  Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy.

Authors:  Shampa Ghosh; Jitendra Kumar Sinha; Tarab Khan; Kuramkote Shivanna Devaraju; Prabhakar Singh; Kumar Vaibhav; Pankaj Gaur
Journal:  Biomedicines       Date:  2021-04-25

3.  Post-ictal Generalized EEG Suppression is reduced by Enhancing Dorsal Raphe Serotonergic Neurotransmission.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Jonathan W Chou; Rui Li; Kimberly M Vencer; Gordon F Buchanan
Journal:  Neuroscience       Date:  2020-11-24       Impact factor: 3.590

4.  Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study.

Authors:  Melissa Krizia Vieri; An Hotterbeekx; Michel Mandro; Joseph Nelson Siewe Fodjo; Alfred Dusabimana; Francoise Nyisi; Deby Mukendi; Joe Gwatsvaira; Samir Kumar-Singh; Robert Colebunders
Journal:  Pathogens       Date:  2021-06-08

5.  Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome.

Authors:  Jing Li; Maxim Nelis; Jo Sourbron; Daniëlle Copmans; Lieven Lagae; Deirdre Cabooter; Peter A M de Witte
Journal:  Neurochem Res       Date:  2021-05-26       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.